Literature DB >> 22548738

Proposed megakaryocytic regulon of p53: the genes engaged to control cell cycle and apoptosis during megakaryocytic differentiation.

Pani A Apostolidis1, Stephan Lindsey, William M Miller, Eleftherios T Papoutsakis.   

Abstract

During endomitosis, megakaryocytes undergo several rounds of DNA synthesis without division leading to polyploidization. In primary megakaryocytes and in the megakaryocytic cell line CHRF, loss or knock-down of p53 enhances cell cycling and inhibits apoptosis, leading to increased polyploidization. To support the hypothesis that p53 suppresses megakaryocytic polyploidization, we show that stable expression of wild-type p53 in K562 cells (a p53-null cell line) attenuates the cells' ability to undergo polyploidization during megakaryocytic differentiation due to diminished DNA synthesis and greater apoptosis. This suggested that p53's effects during megakaryopoiesis are mediated through cell cycle- and apoptosis-related target genes, possibly by arresting DNA synthesis and promoting apoptosis. To identify candidate genes through which p53 mediates these effects, gene expression was compared between p53 knock-down (p53-KD) and control CHRF cells induced to undergo terminal megakaryocytic differentiation using microarray analysis. Among substantially downregulated p53 targets in p53-KD megakaryocytes were cell cycle regulators CDKN1A (p21) and PLK2, proapoptotic FAS, TNFRSF10B, CASP8, NOTCH1, TP53INP1, TP53I3, DRAM1, ZMAT3 and PHLDA3, DNA-damage-related RRM2B and SESN1, and actin component ACTA2, while antiapoptotic CKS1B, BCL2, GTSE1, and p53 family member TP63 were upregulated in p53-KD cells. Additionally, a number of cell cycle-related, proapoptotic, and cytoskeleton-related genes with known functions in megakaryocytes but not known to carry p53-responsive elements were differentially expressed between p53-KD and control CHRF cells. Our data support a model whereby p53 expression during megakaryopoiesis serves to control polyploidization and the transition from endomitosis to apoptosis by impeding cell cycling and promoting apoptosis. Furthermore, we identify a putative p53 regulon that is proposed to orchestrate these effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22548738      PMCID: PMC3426429          DOI: 10.1152/physiolgenomics.00028.2012

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  72 in total

1.  Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process.

Authors:  Larissa Lordier; Yunhua Chang; Abdelali Jalil; Frédéric Aurade; Loïc Garçon; Yann Lécluse; Frédéric Larbret; Toshiyuki Kawashima; Toshio Kitamura; Jérôme Larghero; Najet Debili; William Vainchenker
Journal:  Blood       Date:  2010-06-14       Impact factor: 22.113

2.  The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome.

Authors:  D M Maynard; H F G Heijnen; W A Gahl; M Gunay-Aygun
Journal:  J Thromb Haemost       Date:  2010-05-27       Impact factor: 5.824

Review 3.  Transcriptional regulation by p53.

Authors:  Rachel Beckerman; Carol Prives
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-28       Impact factor: 10.005

4.  Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery.

Authors:  X Shawn Liu; Hongchang Li; Bing Song; Xiaoqi Liu
Journal:  EMBO Rep       Date:  2010-06-25       Impact factor: 8.807

5.  Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line.

Authors:  J C Law; M K Ritke; J C Yalowich; G H Leder; R E Ferrell
Journal:  Leuk Res       Date:  1993-12       Impact factor: 3.156

6.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

7.  Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins.

Authors:  C Serra-Pagès; Q G Medley; M Tang; A Hart; M Streuli
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

8.  Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells.

Authors:  K Ando; F Ajchenbaum-Cymbalista; J D Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

9.  p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

Authors:  M L Agarwal; A Agarwal; W R Taylor; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  The APC/C recruits cyclin B1-Cdk1-Cks in prometaphase before D box recognition to control mitotic exit.

Authors:  Wouter van Zon; Janneke Ogink; Bas ter Riet; René H Medema; Hein te Riele; Rob M F Wolthuis
Journal:  J Cell Biol       Date:  2010-08-23       Impact factor: 10.539

View more
  14 in total

1.  Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia.

Authors:  Kyle R Spinler; Jae-Won Shin; Michele P Lambert; Dennis E Discher
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

2.  Platelets from mice lacking the aryl hydrocarbon receptor exhibit defective collagen-dependent signaling.

Authors:  S Lindsey; J Jiang; D Woulfe; E T Papoutsakis
Journal:  J Thromb Haemost       Date:  2014       Impact factor: 5.824

3.  Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells.

Authors:  Koji Takaishi; Masahiro Takeuchi; Shokichi Tsukamoto; Naoya Takayama; Motohiko Oshima; Kenji Kimura; Yusuke Isshiki; Kensuke Kayamori; Yutaro Hino; Nagisa Oshima-Hasegawa; Shio Mitsukawa; Yusuke Takeda; Naoya Mimura; Chikako Ohwada; Tohru Iseki; Sou Nakamura; Koji Eto; Atsushi Iwama; Koutaro Yokote; Chiaki Nakaseko; Emiko Sakaida
Journal:  Haematologica       Date:  2019-09-05       Impact factor: 9.941

4.  Megakaryocytic Maturation in Response to Shear Flow Is Mediated by the Activator Protein 1 (AP-1) Transcription Factor via Mitogen-activated Protein Kinase (MAPK) Mechanotransduction.

Authors:  Stephanie A Luff; Eleftherios T Papoutsakis
Journal:  J Biol Chem       Date:  2016-01-26       Impact factor: 5.157

5.  BMS-777607 promotes megakaryocytic differentiation and induces polyploidization in the CHRF-288-11 cells.

Authors:  Retno Wahyu Nurhayati; Yoshihiro Ojima; Masahito Taya
Journal:  Hum Cell       Date:  2014-10-11       Impact factor: 4.174

6.  EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia.

Authors:  Sebastian Stasik; Jan M Middeke; Michael Kramer; Christoph Röllig; Alwin Krämer; Sebastian Scholl; Andreas Hochhaus; Martina Crysandt; Tim H Brümmendorf; Ralph Naumann; Björn Steffen; Volker Kunzmann; Hermann Einsele; Markus Schaich; Andreas Burchert; Andreas Neubauer; Kerstin Schäfer-Eckart; Christoph Schliemann; Stefan Krause; Regina Herbst; Mathias Hänel; Norbert Frickhofen; Richard Noppeney; Ulrich Kaiser; Claudia D Baldus; Martin Kaufmann; Zdenek Rácil; Uwe Platzbecker; Wolfgang E Berdel; Jiri Mayer; Hubert Serve; Carsten Müller-Tidow; Gerhard Ehninger; Martin Bornhäuser; Johannes Schetelig; Christian Thiede
Journal:  Haematologica       Date:  2019-08-14       Impact factor: 9.941

7.  MiR-16-5p targets SESN1 to regulate the p53 signaling pathway, affecting myoblast proliferation and apoptosis, and is involved in myoblast differentiation.

Authors:  Bolin Cai; Manting Ma; Biao Chen; Zhenhui Li; Bahareldin Ali Abdalla; Qinghua Nie; Xiquan Zhang
Journal:  Cell Death Dis       Date:  2018-03-06       Impact factor: 8.469

8.  Role of p53 and transcription-independent p53-induced apoptosis in shear-stimulated megakaryocytic maturation, particle generation, and platelet biogenesis.

Authors:  Stephanie A Luff; Chen-Yuan Kao; Eleftherios T Papoutsakis
Journal:  PLoS One       Date:  2018-09-19       Impact factor: 3.240

9.  P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis.

Authors:  Emna Mahfoudhi; Larissa Lordier; Caroline Marty; Jiajia Pan; Anita Roy; Lydia Roy; Philippe Rameau; Salem Abbes; Najet Debili; Hana Raslova; Yunhua Chang; Laurent Debussche; William Vainchenker; Isabelle Plo
Journal:  Oncotarget       Date:  2016-05-31

10.  Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms.

Authors:  Jacques A J Malherbe; Kathryn A Fuller; Bob Mirzai; Simon Kavanagh; Chi-Chiu So; Ho-Wan Ip; Belinda B Guo; Cecily Forsyth; Rebecca Howman; Wendy N Erber
Journal:  J Clin Pathol       Date:  2016-04-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.